59 completed, 10 unknown, 9 recruiting, 6 terminated. 32 Not applicable, 32 Phase 2, 22 Phase 3, 9 Phase 1, 7 Phase 4.
Follow Comparator: new trials by email Literature Review of Comparator trials Research Report on Comparator
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shower Gel and Participant-Reported Post-Exercise Soreness in Regular Exercisers Topical shower gel, Comparator - Post-Exercise Recovery, Muscle Soreness | Not applicable | Recruiting | The Humanix | 100 | 2026-11-01 | 2026-11-02 |
| Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo Candidate BDBV vaccine, Active comparator - Ebola Hemorrhagic Fever, Bundibugyo Virus Disease | Phase 2 / Phase 3 | Not yet recruiting | Jean-Pierre Van geertruyden | 3620 | 2026-10-20 | 2026-10-05 |
| Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial- EMONO, Medical air - Depression, Neurocognitive Disorders | Phase 2 | Not yet recruiting | University Hospital, Tours | 96 | 2026-09-01 | 2026-06-17 |
| World Sight Foundation Field Machine (WSFFM) Pilot World Sight Foundation Field Machine, Comparator - Glaucoma | Not applicable | Recruiting | Buckinghamshire Healthcare NHS Trust | 100 | 2026-04-29 | 2026-06-29 |
| Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea Comparator, Interventions - Crossbite Teeth | Not yet recruiting | October University for Modern Sciences and Arts | 420 | 2026-04-01 | 2026-05-01 | |
| Clinical Investigation Exploring a Newly Developed Ostomy Baseplate Incestigational device, Comparator - Stoma Ileostomy | Not applicable | Completed | Coloplast A/S | 20 | 2026-01-24 | 2026-05-01 |
| The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction Remimazolam, Propofol (Group P) - Cerebral Blood Flow | Phase 3 | Completed | Jun Zhang | 52 | 2025-12-29 | 2026-04-15 |
| Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food Bottarga, Comparator - Prediabetes, Diabetes | Not applicable | Recruiting | Cambridge Health Alliance | 20 | 2025-10-17 | 2026-07-16 |
| SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds Suprathel 250, Comparator - Tonsillitis, Tonsillectomy | Not applicable | Recruiting | Alaa Emara | 80 | 2025-04-30 | 2026-07-27 |
| 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) 61Cu-NODAGA-LM3, Comparator - Neuroendocrine Tumors | Phase 1 / Phase 2 | Recruiting | University Hospital, Basel, Switzerland | 27 | 2025-02-05 | 2025-05-30 |
| Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma Experimental, Comparator - Perennial Allergic Rhinitis Accompanied by Asthma | Phase 3 | Recruiting | Daewon Pharmaceutical Co., Ltd. | 274 | 2024-09-09 | 2025-09-11 |
| Brivaracetam Bioequivalence Assessment Briveka ® 100 mg, Briviact® 100 mg - Bioequivalence Study in Healthy Subjects | Phase 1 | Completed | Zodiac Produtos Farmaceuticos S.A. | 28 | 2024-08-09 | 2026-09-02 |
| Proof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity Prednisone - Hepatotoxicity, Idiosyncratic Drug Effect | Phase 2 | Not yet recruiting | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 60 | 2024-05-01 | 2024-04-05 |
| SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) SC1011, Placebo comparator - Idiopathic Pulmonary Fibrosis | Phase 2 / Phase 3 | Recruiting | Guangzhou JOYO Pharma Co., Ltd | 210 | 2023-06-06 | 2024-11-19 |
| The Effect of Therapeutic Exercise on Cartilage Morphology and Physical Function for Individuals at High Risk of Knee Osteoarthritis Progressive Resistance Exercise (PRE), Aerobic Exercise, Control - Meniscus Tear | Not applicable | Recruiting | Jordan University of Science and Technology | 50 | 2023-06-01 | 2026-05-12 |
| A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer [177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11 - Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 63 | 2023-05-05 | 2026-03-23 |
| Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face TEOSYAL® TPVM, COMPARATOR - Aging, Chin Retrusion | Not applicable | Active not recruiting | Teoxane SA | 155 | 2023-04-06 | 2025-09-03 |
| Using Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD) ACCEPT Decision Intervention, Comparator - Chronic Obstructive Pulmonary Disease | Not applicable | Unknown | University of British Columbia | 1130 | 2023-03-21 | 2023-05-10 |
| Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection Umbilical cord mesenchymal stem cells implantation, Comparator - COVID-19 | Phase 1 / Phase 2 | Unknown | Hebei Medical University | 20 | 2023-01-28 | 2023-02-23 |
| Evaluation of Dexterous Terminal Device Pointdexter, Comparator - Amputation, Amputation, Traumatic | Not applicable | Withdrawn | Liberating Technologies, Inc. | 2022-12-22 | 2024-11-25 |
Showing 20 of 95. Sign in to see all of them.
Asthma (3) · Diabetes Mellitus (3) · Osteoarthritis, Knee (3) · COVID-19 (2) · Diabetes Mellitus, Type 2 (2) · Influenza, Human (2) · Peripheral Arterial Disease (2) · Pulmonary Disease, Chronic Obstructive (2) · Abdominal Injuries (1) · Acute Pain (1) · Alzheimer Disease (1) · Amputation, Traumatic (1) · Ankylosis (1) · Anxiety Disorders (1) · Arterial Occlusive Diseases (1)
Allergopharma GmbH & Co. KG (9) · Coloplast A/S (4) · Novartis Pharmaceuticals (3) · Autifony Therapeutics Limited (2) · Duke University (2) · Fresenius Kabi (2) · Medy-Tox (2) · Seqirus (2) · Tecno Sun SRL (2) · ACTEON Group (1) · AbbVie (1) · Alaa Emara (1) · Amylyx Pharmaceuticals Inc. (1) · Amzell (1) · Andre Denault (1)
United States (18) · Germany (14) · Canada (9) · China (9) · United Kingdom (7) · Brazil (5) · South Korea (5) · Denmark (4) · Poland (4) · Ukraine (4) · Czechia (3) · France (3) · Netherlands (3) · South Africa (3) · Spain (3)
Annemie Narkus, M.D. (3) · David Crowley, MD (2) · Ahmed Ayman (1) · Alaa Emara (1) · Amin Javer, MD (1) · Ashutosh K Singh, MDS (1) · Ashwin Chatwani, MD (1) · Baoyong Yan, Master (1) · Birte Jakobsen, MD (1) · Chi-Hsiao Yeh, MD pHD (1)
PMID 12766097, PMID 15876311, PMID 17274520, PMID 17523386, PMID 18426146, PMID 20624650, PMID 22939758, PMID 23621350, PMID 24041858, PMID 25006684, PMID 25329189, PMID 27052991, PMID 27109816, PMID 27199777, PMID 27470232, PMID 28344643, PMID 29406465, PMID 29629845, PMID 29859173, PMID 30648126, PMID 30939361, PMID 31837050, PMID 31978293, PMID 31986257, PMID 32085846, PMID 32257537, PMID 32811531, PMID 33514427, PMID 34256810, PMID 34611902, PMID 34750382, PMID 36782301, PMID 37142273, PMID 37781954, PMID 37941072, PMID 39131742, PMID 39293462, PMID 40233296, PMID 40441170, PMID 40680993, PMID 41461276, PMID 41962984, PMID 42048080, PMID 42057342
2023 (3), 2004 (1), 2005 (1), 2008 (1), 2016 (1), 2018 (1), R21CA245456 (1), R21MH087928 (1)